Sbi Securities Co., Ltd. Connect Biopharma Holdings LTD Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 6 shares of CNTB stock, worth $6. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6Holding current value
$6% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CNTB
# of Institutions
13Shares Held
3.26MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.09MShares$2.18 Million1.77% of portfolio
-
Ubs Oconnor LLC Chicago, IL511KShares$531,1290.05% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny176KShares$182,5200.0% of portfolio
-
Choreo, LLC Minneapolis, MN161KShares$167,3010.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$108,0460.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $57.2M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...